374 related articles for article (PubMed ID: 27573663)
21. Molecular genetics and therapeutic targets of pediatric low-grade gliomas.
Tateishi K; Nakamura T; Yamamoto T
Brain Tumor Pathol; 2019 Apr; 36(2):74-83. PubMed ID: 30929113
[TBL] [Abstract][Full Text] [Related]
22. Responsiveness of progressive optic pathway tumors to cisplatin-based chemotherapy in children.
Hsu TR; Wong TT; Chang FC; Ho DM; Tang RB; Thien PF; Chang KP
Childs Nerv Syst; 2008 Dec; 24(12):1457-61. PubMed ID: 18769928
[TBL] [Abstract][Full Text] [Related]
23. Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma.
Indelicato DJ; Rotondo RL; Uezono H; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Bradley JA
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):149-156. PubMed ID: 30684665
[TBL] [Abstract][Full Text] [Related]
24. Transient Hepatotoxicity Induced by Vinblastine in a Young Girl with Chiasmatic Low Grade Glioma.
Franke NE; Blok GJ; Voll ML; Schouten-van Meeteren AYN
Curr Drug Saf; 2020; 15(3):231-235. PubMed ID: 32682382
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy with cisplatin and vincristine for optic pathway/hypothalamic astrocytoma in young children.
Sawamura Y; Kamoshima Y; Kato T; Tajima T; Tsubaki J
Jpn J Clin Oncol; 2009 May; 39(5):277-83. PubMed ID: 19224939
[TBL] [Abstract][Full Text] [Related]
26. Loss of efficacy of subsequent nonsurgical therapy after primary treatment failure in pediatric low-grade glioma patients-Report from the German SIOP-LGG 2004 cohort.
Kandels D; Pietsch T; Bison B; Warmuth-Metz M; Thomale UW; Kortmann RD; Timmermann B; Hernáiz Driever P; Witt O; Schmidt R; Gnekow AK
Int J Cancer; 2020 Dec; 147(12):3471-3489. PubMed ID: 32580249
[TBL] [Abstract][Full Text] [Related]
27. Response in a child with a BRAF V600E mutated desmoplastic infantile astrocytoma upon retreatment with vemurafenib.
van Tilburg CM; Selt F; Sahm F; Bächli H; Pfister SM; Witt O; Milde T
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29230924
[TBL] [Abstract][Full Text] [Related]
28. Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution.
Colin C; Padovani L; Chappé C; Mercurio S; Scavarda D; Loundou A; Frassineti F; André N; Bouvier C; Korshunov A; Lena G; Figarella-Branger D
Neuropathol Appl Neurobiol; 2013 Oct; 39(6):693-705. PubMed ID: 23278243
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report.
Burzynski SR; Weaver RA; Lewy RI; Janicki TJ; Jurida GF; Szymkowski BG; Khan MI; Bestak M
Drugs R D; 2004; 5(6):315-26. PubMed ID: 15563234
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of carboplatin in children with progressive low-grade gliomas.
Gururangan S; Cavazos CM; Ashley D; Herndon JE; Bruggers CS; Moghrabi A; Scarcella DL; Watral M; Tourt-Uhlig S; Reardon D; Friedman HS
J Clin Oncol; 2002 Jul; 20(13):2951-8. PubMed ID: 12089224
[TBL] [Abstract][Full Text] [Related]
31. [Weekly Vinblastine in Pediatric Optic Pathway/Hypothalamic Glioma:2 Cases Report].
Yamasaki F; Takano M; Yonezawa U; Taguchi A; Takayasu T; Sugiyama K; Kurisu K
No Shinkei Geka; 2019 Sep; 47(9):977-984. PubMed ID: 31564659
[TBL] [Abstract][Full Text] [Related]
32. Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial.
Cortés J; Dieras V; Ro J; Barriere J; Bachelot T; Hurvitz S; Le Rhun E; Espié M; Kim SB; Schneeweiss A; Sohn JH; Nabholtz JM; Kellokumpu-Lehtinen PL; Taguchi J; Piacentini F; Ciruelos E; Bono P; Ould-Kaci M; Roux F; Joensuu H
Lancet Oncol; 2015 Dec; 16(16):1700-10. PubMed ID: 26596672
[TBL] [Abstract][Full Text] [Related]
33. A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.
Perreault S; Larouche V; Tabori U; Hawkin C; Lippé S; Ellezam B; Décarie JC; Théoret Y; Métras MÉ; Sultan S; Cantin É; Routhier MÈ; Caru M; Legault G; Bouffet É; Lafay-Cousin L; Hukin J; Erker C; Jabado N
BMC Cancer; 2019 Dec; 19(1):1250. PubMed ID: 31881853
[TBL] [Abstract][Full Text] [Related]
34. Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital.
Gajjar A; Sanford RA; Heideman R; Jenkins JJ; Walter A; Li Y; Langston JW; Muhlbauer M; Boyett JM; Kun LE
J Clin Oncol; 1997 Aug; 15(8):2792-9. PubMed ID: 9256121
[TBL] [Abstract][Full Text] [Related]
35. ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor Consortium.
Vajapeyam S; Brown D; Ziaei A; Wu S; Vezina G; Stern JS; Panigrahy A; Patay Z; Tamrazi B; Jones JY; Haque SS; Enterline DS; Cha S; Jones BV; Yeom KW; Onar-Thomas A; Dunkel IJ; Fouladi M; Fangusaro JR; Poussaint TY
AJNR Am J Neuroradiol; 2022 Mar; 43(3):455-461. PubMed ID: 35210278
[TBL] [Abstract][Full Text] [Related]
36. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
[TBL] [Abstract][Full Text] [Related]
37. Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors.
Lee RP; Foster KA; Lillard JC; Klimo P; Ellison DW; Orr B; Boop FA
J Neurosurg Pediatr; 2017 Sep; 20(3):247-255. PubMed ID: 28686121
[TBL] [Abstract][Full Text] [Related]
38. Conformal Radiation Therapy for Pediatric Patients with Low-Grade Glioma: Results from the Children's Oncology Group Phase 2 Study ACNS0221.
Cherlow JM; Shaw DWW; Margraf LR; Bowers DC; Huang J; Fouladi M; Onar-Thomas A; Zhou T; Pollack IF; Gajjar A; Kessel SK; Cullen PL; McMullen K; Wellons JC; Merchant TE
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):861-868. PubMed ID: 30419305
[TBL] [Abstract][Full Text] [Related]
39. Temozolomide in children with progressive low-grade glioma.
Gururangan S; Fisher MJ; Allen JC; Herndon JE; Quinn JA; Reardon DA; Vredenburgh JJ; Desjardins A; Phillips PC; Watral MA; Krauser JM; Friedman AH; Friedman HS
Neuro Oncol; 2007 Apr; 9(2):161-8. PubMed ID: 17347491
[TBL] [Abstract][Full Text] [Related]
40. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.
Skapek SX; Ferguson WS; Granowetter L; Devidas M; Perez-Atayde AR; Dehner LP; Hoffer FA; Speights R; Gebhardt MC; Dahl GV; Grier HE;
J Clin Oncol; 2007 Feb; 25(5):501-6. PubMed ID: 17290057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
